Oxford BioTherapeutics Appoints Bryan G. Morton as Chairman

Published: Jun 26, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

OXFORD, England, June 26, 2013 /PRNewswire/ --

Oxford BioTherapeutics (OBT), a global biotechnology company developing first-in-class, antibody-based cancer medicines to fulfil unmet patient needs, today announces the appointment of Bryan G. Morton as the Company's new Non-executive Chairman.

Help employers find you! Check out all the jobs and post your resume.

Back to news